Siegel RL, Miller KD, Fuchs HE, Jemal A. Most cancers statistics, 2022. CA Most cancers J Clin. 2022;72:7–33.
Mattiuzzi C, Lippi G. Present Most cancers Epidemiology glossary. J Epidemiol Glob Well being. 2019;9:217–22.
Debien V, De Caluwé A, Wang X, Piccart-Gebhart M, Tuohy VK, Romano E, et al. Immunotherapy in breast most cancers: an summary of present methods and views. NPJ Breast Most cancers. 2023;9:1–10.
Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic panorama in major and metastatic liver most cancers. Nat Rev Most cancers. 2021;21:541–57.
Oudkerk M, Liu SY, Heuvelmans MA, Walter JE, Discipline JK. Lung most cancers LDCT screening and mortality discount—proof, pitfalls and future views. Nat Rev Clin Oncol. 2021;18:135–51.
Schlumberger M, Leboulleux S. Present follow in sufferers with differentiated thyroid most cancers. Nat Rev Endocrinol. 2021;17:176–88.
Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate most cancers. Eur Urol Oncol. 2021;4:877–92.
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. International estimates of incidence and mortality of cervical most cancers in 2020: a baseline evaluation of the WHO International Cervical Most cancers Elimination Initiative. Lancet Glob Well being. 2023;11:e197–206.
Van HLMC, Vrieling A, Van Der HAG, Kogevinas M, Richters A, Kiemeney LA. International traits within the epidemiology of bladder most cancers : challenges for public well being and medical follow. Nat Rev Clin Oncol. 2023;20:287–304.
Esmeeta A, Adhikary S, Dharshnaa V, Swarnamughi P, Ummul Maqsummiya Z, Banerjee A, et al. Plant-derived bioactive compounds in colon most cancers remedy: an up to date assessment. Biomed Pharmacother. 2022;153: 113384.
Mirza MR, Chase DM, Slomovitz BM, dePont CR, Novák Z, Black D, et al. Dostarlimab for major superior or recurrent endometrial most cancers. N Engl J Med. 2023;388:2145–58.
Choueiri TK, Albiges L, Atkins MB, Bakouny Z, Bratslavsky G, Braun DA, et al. From primary science to medical translation in kidney most cancers: a report from the second kidney most cancers analysis summit. Clin Most cancers Res. 2022;28:831–9.
Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel Ok, Cavo M, Nooka AK, et al. Ide-cel or normal regimens in relapsed and refractory a number of myeloma. N Engl J Med. 2023;388:1002–14.
Armitage JO, Lengthy DL. Mantle-cell lymphoma. N Engl J Med. 2022;386:2495–506.
Hingorani SR. Epithelial and stromal co-evolution and complicity in pancreatic most cancers. Nat Rev Most cancers. 2023;23:57–77.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, et al. Zanubrutinib or Ibrutinib in relapsed or refractory continual lymphocytic leukemia. N Engl J Med. 2023;388:319–32.
Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR, et al. Neoadjuvant–adjuvant or adjuvant-only pembrolizumab in superior melanoma. N Engl J Med. 2023;388:813–23.
Nakhoda S, Vistarop A, Wang YL. Resistance to Bruton tyrosine kinase inhibition in continual lymphocytic leukaemia and non-Hodgkin lymphoma. Br J Haematol. 2023;200:137–49.
Pashayan N, Pharoah PDP. The problem of early detection in most cancers. Science. 1979;2020(368):589–90.
Li X, Bao Y, Li Z, Teng P, Ma L, Zhang H, et al. Using antagonistic C-X-C motif chemokine receptor 4 antagonistic peptide functionalized NaGdF4 nanodots for magnetic resonance imaging-guided biotherapy of breast most cancers. Sci Rep. 2024;14:15764.
Kumar Sarangi M, Padhi S, Rath G, Sekhar Nanda S, Kee YD. Advances in immunological and theranostic approaches of gold nanoparticles—a assessment. Inorg Chem Commun. 2023;153:110858.
Dutta Gupta Y, Mackeyev Y, Krishnan S, Bhandary S. Mesoporous silica nanotechnology: promising advances in augmenting most cancers theranostics. Most cancers Nanotechnol. 2024;15:1–44.
Hosseini SM, Mohammadnejad J, Salamat S, Beiram Zadeh Z, Tanhaei M, Ramakrishna S. Theranostic polymeric nanoparticles as a brand new method in most cancers remedy and prognosis: a assessment. Mater Right this moment Chem. 2023;29: 101400.
Yukawa H, Sato Ok, Baba Y. Theranostics functions of quantum dots in regenerative medication, most cancers medication, and infectious illnesses. Adv Drug Deliv Rev. 2023;200:114863.
Ma Q, Cao Y, Ge X, Zhang Z, Gao S, Tune J. X-ray excited luminescence supplies for most cancers prognosis and theranostics. Laser Photon Rev. 2024;18:2300565.
Al-Thani AN, Jan AG, Abbas M, Geetha M, Sadasivuni KK. Nanoparticles in most cancers theragnostic and drug supply: a complete assessment. Life Sci. 2024;352: 122899.
Rahimkhoei V, Alzaidy AH, Abed MJ, Rashki S, Salavati-Niasari M. Advances in inorganic nanoparticles-based drug supply in focused breast most cancers theranostics. Adv Colloid Interface Sci. 2024;329: 103204.
Jin GQ, Chau CV, Arambula JF, Gao S, Sessler JL, Zhang JL. Lanthanide porphyrinoids as molecular theranostics. Chem Soc Rev. 2022;51:6177–209.
Domingues I, Pereira G, Martins P, Duarte H, Santos J, Abreu PH. Utilizing deep studying methods in medical imaging: a scientific assessment of functions on CT and PET. Artif Intell Rev. 2020;53:4093–160.
Hsu JC, Nieves LM, Betzer O, Sadan T, Noël PB, Popovtzer R, et al. Nanoparticle distinction brokers for X-ray imaging functions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:1–26.
Wu Q, Zheng Q, He Y, Chen Q, Yang H. Rising nanoagents for medical x-ray imaging. Anal Chem. 2023;95:33–48.
Solar W, Zhou Z, Pratx G, Chen X, Chen H. Nanoscintillator-mediated X-ray induced photodynamic remedy for deep-seated tumors: from idea to biomedical functions. Theranostics. 2020;10:1296–318.
Yu X, Liu X, Yang Ok, Chen X, Li W. Pnictogen semimetal (Sb, Bi)-based nanomaterials for most cancers imaging and remedy: a supplies perspective. ACS Nano. 2021;15:2038–67.
Pires L, Calcada C, Grafinger O, Juneja R, Mar S, Leong H, et al. Photosensitizers as radiosensitizers for metastatic and deep-seated tumors: in vitro and ex-ovo preclinical research. Photodiagnosis Photodyn Ther. 2023;41: 103422.
Belanova A, Chmykhalo V, Beseda D, Belousova M, Butova V, Soldatov A, et al. A mini-review of X-ray photodynamic remedy (XPDT) nonoagent constituents’ security and related design concerns. Photochem Photobiol Sci. 2020;19:1134–44.
Fan W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic remedy. Chem Soc Rev. 2016;45:6488–519.
Chen X, Tune J, Chen X, Yang H. X-ray-activated nanosystems for theranostic functions. Chem Soc Rev. 2019;48:3073–101.
Kirakci Ok, Kubát P, Fejfarova Ok, Martinčík J, Nikl M, Lang Ok. X-ray inducible luminescence and singlet oxygen sensitization by an octahedral molybdenum cluster compound: a brand new class of nanoscintillators. Inorg Chem. 2016;55:803–9.
Lei L, Wang Y, Kuzmin A, Hua Y, Zhao J, Xu S, et al. Subsequent era lanthanide doped nanoscintillators and photon converters. eLight. 2022;2:1–24.
Bulin A-L, Vasil’ev A, Belsky A, Amans D, Ledoux G, Dujardin C. Modelling power deposition in nanoscintillators to foretell the effectivity of the X-ray-induced photodynamic impact. Nanoscale. 2015;7:5744–51.
Yu X, Liu X, Wu W, Yang Ok, Mao R, Ahmad F, et al. CT/MRI-guided synergistic radiotherapy and X-ray inducible photodynamic remedy utilizing Tb-doped Gd-W-nanoscintillators. Angew Chem. 2019;131:2039–44.
Tune G, Cheng L, Chao Y, Yang Ok, Liu Z. Rising nanotechnology and superior supplies for most cancers radiation remedy. Adv Mater. 2017;29:1–26.
Shen S, Jiang D, Cheng L, Chao Y, Nie Ok, Dong Z, et al. Renal-clearable ultrasmall coordination polymer nanodots for chelator-free 64Cu-labeling and imaging-guided enhanced radiotherapy of most cancers. ACS Nano. 2017;11:9103–11.
Zhang XD, Chen J, Min Y, Park GB, Shen X, Tune SS, et al. Metabolizable Bi2Se3 nanoplates: biodistribution, toxicity, and makes use of for most cancers radiation remedy and imaging. Adv Funct Mater. 2014;24:1718–29.
Gong T, Li Y, Lv B, Wang H, Liu Y, Yang W, et al. Full-process radiosensitization based mostly on nanoscale metal-organic frameworks. ACS Nano. 2020;14:3032–40.
Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-based nanomedicine. Chem Rev. 2019;119:4881–985.
Kirsanova DY, Gadzhimagomedova ZM, Maksimov AY, Soldatov AV. Nanomaterials for deep tumor remedy. Mini Rev Med Chem. 2021;21:677–88.
Popovich Ok, Procházková L, Pelikánová IT, Vlk M, Palkovský M, Jarý V, et al. Preliminary research on singlet oxygen manufacturing utilizing CeF3:Tb3+@SiO2-PpIX. Radiat Meas. 2016;90:325–8.
Zhang Q, Guo X, Cheng Y, Chudal L, Pandey NK, Zhang J, et al. Use of copper-cysteamine nanoparticles to concurrently allow radiotherapy, oxidative remedy and immunotherapy for melanoma remedy. Sign Transduct Goal Ther. 2020;5:4–6.
Ma L, Zou X, Chen W. A brand new X-ray activated nanoparticle photosensitizer for most cancers remedy. J Biomed Nanotechnol. 2014;10:1501–8.
Ma L, Zou X, Bui B, Chen W, Tune KH, Solberg T. X-ray excited ZnS:Cu, Co afterglow nanoparticles for photodynamic activation. Appl Phys Lett. 2014;105: 013702.
Gadzhimagomedova Z, Zolotukhin P, Package O, Kirsanova D, Soldatov A. Nanocomposites for X-ray photodynamic remedy. Int J Mol Sci. 2020;21:1–15.
Sengar P, Garcia-Tapia Ok, Chauhan Ok, Jain A, Juarez-Moreno Ok, Borbón-Nuñez HA, et al. Dualphotosensitizer coupled nanoscintillator able to producing sort I and sort II ROS for subsequent era photodynamic remedy. J Colloid Interface Sci. 2019;536:586–97.
Zhang W, Zhang X, Shen Y, Shi F, Tune C, Liu T, et al. Extremely-high FRET effectivity NaGdF4: Tb3+-Rose Bengal biocompatible nanocomposite for X-ray excited photodynamic remedy software. Biomaterials. 2018;184:31–40.
Chen MH, Jenh YJ, Wu SK, Chen YS, Hanagata N, Lin FH. Non-invasive photodynamic remedy in mind most cancers by use of Tb3+-doped LaF3 nanoparticles together with photosensitizer by means of X-ray irradiation: a proof-of-concept research. Nanoscale Res Lett. 2017;12:1–6.
Elmenoufy AH, Tang Y, Hu J, Xu H, Yang X. A novel deep photodynamic remedy modality mixed with CT imaging established through X-ray stimulated silica-modified lanthanide scintillating nanoparticles. Chem Commun. 2015;51:12247–50.
Bulin A-L, Truillet C, Chouikrat R, Lux F, Frochot C, Amans D, et al. X-ray-induced singlet oxygen activation with nanoscintillator-coupled porphyrins. J Phys Chem C. 2013;117:21583–9.
Kaščáková S, Giuliani A, Lacerda S, Pallier A, Mercère P, Tóth É, et al. X-ray-induced radiophotodynamic remedy (RPDT) utilizing lanthanide micelles: past depth limitations. Nano Res. 2015;8:2373–9.
Zhang X, Lan B, Wang S, Gao P, Liu T, Rong J, et al. Low-dose X-ray excited photodynamic remedy based mostly on NaLuF4:Tb3+-Rose Bengal nanocomposite. Bioconjug Chem. 2019;30:2191–200.
Popovich Ok, Tomanová Ok, Čuba V, Procházková L, Pelikánová IT, Jakubec I, et al. LuAG:Pr3+-porphyrin based mostly nanohybrid system for singlet oxygen manufacturing: towards the subsequent era of PDTX medicine. J Photochem Photobiol B. 2018;179:149–55.
Procházková L, Pelikánová IT, Mihóková E, Dědic R, Čuba V. Novel scintillating nanocomposite for X-ray induced photodynamic remedy. Radiat Meas. 2019;121:13–7.
Procházková L, Čuba V, Beitlerová A, Jarý V, Omelkov S, Nikl M. Ultrafast Zn(Cd, Mg)O: Ga nanoscintillators with luminescence tunable by band hole modulation. Choose Categorical. 2018;26:29482–94.
Wang GD, Nguyen HT, Chen H, Cox PB, Wang L, Nagata Ok, et al. X-ray induced photodynamic remedy: a mixture of radiotherapy and photodynamic remedy. Theranostics. 2016;6:2295–305.
Bekah D, Cooper D, Kudinov Ok, Hill C, Seuntjens J, Bradforth S, et al. Synthesis and characterization of biologically secure, doped LaF3 nanoparticles co-conjugated to PEG and photosensitizers. J Photochem Photobiol A Chem. 2016;329:26–34.
Zou X, Yao M, Ma L, Hossu M, Han X, Juzenas P, et al. X-ray-induced nanoparticle-based photodynamic remedy of most cancers. Nanomedicine. 2014;9:2339–51.
Sapre AA, Novitskaya E, Vakharia V, Cota A, Wrasidlo W, Hanrahan SM, et al. Optimized scintillator YAG: Pr nanoparticles for X-ray inducible photodynamic remedy. Mater Lett. 2018;228:49–52.
Kaszewski J, Olszewski J, Rosowska J, Witkowski B, Wachnicki Ł, Wenelska Ok, et al. HfO2: Eu nanoparticles excited by X-rays and UV-visible radiation utilized in organic imaging. J Uncommon Earths. 2019;37:1176–82.
Li X, Xue Z, Jiang M, Li Y, Zeng S, Liu H. Comfortable X-ray activated NaYF4:Gd/Tb scintillating nanorods for in vivo dual-modal X-ray/X-ray-induced optical bioimaging. Nanoscale. 2018;10:342–50.
Generalov R, Kuan WB, Chen W, Kristensen S, Juzenas P. Radiosensitizing impact of zinc oxide and silica nanocomposites on most cancers cells. Colloids Surf B Biointerfaces. 2015;129:79–86.
Zagami P, Carey LA. Triple damaging breast most cancers: pitfalls and progress. NPJ Breast Most cancers. 2022;8:1–10.
Perou CM, Sorlie T, Eisen MB, Van De RM, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;533:747–52.
Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 varieties of most cancers. Cell. 2019;173:291–304.
Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, et al. Occasion-free survival with pembrolizumab in early triple-negative breast most cancers. N Engl J Med. 2022;386:556–67.
Wang X, Solar W, Shi H, Ma H, Niu G, Li Y, et al. Natural phosphorescent nanoscintillator for low-dose X-ray-induced photodynamic remedy. Nat Commun. 2022;13:1–9.
Zhang B, Liu H, Wang Y, Zhang Y, Cheng J. Utility of singlet oxygen-activatable nanocarriers to spice up X-ray-induced photodynamic remedy and cascaded ferroptosis for breast most cancers remedy. J Mater Chem B. 2023;11:9685–96.
Jain A, Koyani R, Muñoz C, Sengar P, Contreras OE, Juárez P, et al. Magnetic-luminescent cerium-doped gadolinium aluminum garnet nanoparticles for simultaneous imaging and photodynamic remedy of most cancers cells. J Colloid Interface Sci. 2018;526:220–9.
Maiti D, Yu H, Kim BS, Naito M, Yamashita S, Kim HJ, et al. Rose Bengal embellished NaYF4: Tb nanoparticles for low dose X-ray-induced photodynamic remedy in most cancers cells. ACS Appl Bio Mater. 2022;5:5477–86.
Maiti D, Yu H, Mochida Y, Received S, Yamashita S, Naito M, et al. Terbium-Rose Bengal coordination nanocrystals-induced ROS manufacturing below low-dose X-rays in cultured most cancers cells for photodynamic remedy. ACS Appl Bio Mater. 2023;6:2505–13.
Chen X, Liu J, Li Y, Pandey NK, Chen T, Wang L, et al. Research of copper-cysteamine based mostly X-ray induced photodynamic remedy and its results on most cancers cell proliferation and migration in a medical mimic setting. Bioact Mater. 2022;7:504–14.
Zhang B, Xue R, Lyu J, Gao A, Solar C. Tumor acidity/redox hierarchical-activable nanoparticles for exact mixture of X-ray-induced photodynamic remedy and hypoxia-activated chemotherapy. J Mater Chem B. 2022;10:3849–60.
Sengar P, Juárez P, Meza AV, Arellano DL, Jain A, Chauhan Ok, et al. Improvement of a functionalized UV-emitting nanocomposite for the remedy of most cancers utilizing oblique photodynamic remedy. J Nanobiotechnol. 2018;16:1–19.
Jiang F, Lee C, Zhang W, Jiang W, Cao Z, Chong HB, et al. Radiodynamic remedy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid. J Nanobiotechno. 2022;20:1–15.
Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450–62.
Yang JD, Roberts LR. Hepatocellular carcinoma: a worldwide view. Nat Rev Gastroenterol Hepatol. 2010;7:448–58.
Sia D, Villanueva A, Friedman SL, Llovet JM. Liver most cancers cell of origin, molecular class, and results on affected person prognosis. Gastroenterology. 2017;152:745–61.
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Tips for the prognosis and administration of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.
Cao J, Wang J, He C, Fang M. Angiosarcoma: a assessment of prognosis and present remedy. Am J Most cancers Res. 2019;9:2303–13.
Fitzmaurice C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of major liver most cancers and underlying etiologies from 1990 to 2015 on the world, regional, and nationwide stage outcomes from the worldwide burden of illness research 2015. JAMA Oncol. 2017;3:1683–91.
Celsa C, Stornello C, Giuffrida P, Giacchetto CM, Grova M, Rancatore G, et al. Direct-acting antiviral brokers and danger of Hepatocellular carcinoma: essential appraisal of the proof. Ann Hepatol. 2022;27: 100568.
Zhen X, Pandey NK, Amador E, Hu W, Liu B, Nong W, et al. Potassium iodide enhances the anti-hepatocellular carcinoma impact of copper-cysteamine nanoparticle mediated photodynamic remedy on most cancers remedy. Mater Right this moment Phys. 2022;27: 100838.
Vasuri F, Renzulli M, Fittipaldi S, Brocchi S, Clemente A, Cappabianca S, et al. Pathobiological and radiological method for hepatocellular carcinoma subclassification. Sci Rep. 2019;9:1–10.
Mushtaq A, Iqbal MZ, Kong X. Antiviral results of coinage metal-based nanomaterials to fight COVID-19 and its variants. J Mater Chem B. 2022;10:5323–43.
Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung most cancers. The Lancet. 2021;398:535–54.
Araujo LH, Horn L, Merritt RE, Shilo Ok, Xu-Welliver M, Carbone DP. 69—Most cancers of the lung: non-small cell lung most cancers and small cell lung most cancers. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, editors. Abeloff’s medical oncology. Amsterdam: Elsevier; 2020.
Jiang Y, Su Z, Liang H, Liu J, Liang W, He J. Video-assisted thoracoscopy for lung most cancers: Who’s the way forward for thoracic surgical procedure? J Thorac Dis. 2020;12:4427–33.
Baker S, Dahele M, Lagerwaard FJ, Senan S. A essential assessment of latest developments in radiotherapy for non-small cell lung most cancers. Radiat Oncol. 2016;11:1–14.
Yang CC, Wang WY, Lin FH, Hou CH. Uncommon-earth-doped calcium carbonate uncovered to X-ray irradiation to induce reactive oxygen species for tumor remedy. Int J Mol Sci. 2019;20:1148.
Herbst RS, Baas P, Kim DW, Felip E, Pérez-Gracia JL, Han JY, et al. Pembrolizumab versus docetaxel for beforehand handled, PD-L1-positive, superior non-small-cell lung most cancers (KEYNOTE-010): a randomised managed trial. The Lancet. 2016;387:1540–50.
Chen H, Solar X, Wang GD, Nagata Ok, Hao Z, Wang A, et al. LiGa5O8:Cr-based theranostic nanoparticles for imaging-guided X-ray induced photodynamic remedy of deep-seated tumors. Mater Horiz. 2017;4:1092–101.
Rossi F, Bedogni E, Bigi F, Rimoldi T, Cristofolini L, Pinelli S, et al. Porphyrin conjugated SiC/SiOx nanowires for X-ray-excited photodynamic remedy. Sci Rep. 2015;5:1–6.
Yang DM, Cvetkovic D, Chen L, Ma CMC. Therapeutic results of in-vivo radiodynamic remedy (RDT) for lung most cancers remedy: a mixture of 15 MV photons and 5-aminolevulinic acid (5-ALA). Biomed Phys Eng Categorical. 2022;8: 065031.
Sanchez G, Nova J, Rodriguez-Hernandez AE, Solorzano-Restrepo C, Gonzalez J, Olmos M, et al. Solar safety for stopping basal cell and squamous cell pores and skin cancers. Cochrane Database Syst Rev. 2016;2016:1–32.
Domingues B, Lopes JM, Soares P, Pópulo H. Melanoma remedy in assessment. Immunotargets Ther. 2018;7:35–49.
Hu W, Fang L, Ni R, Zhang H, Pan G. Altering traits within the illness burden of non-melanoma pores and skin most cancers globally from 1990 to 2019 and its predicted stage in 25 years. BMC Most cancers. 2022;22:1–11.
Shi L, Liu P, Wu J, Ma L, Zheng H, Antosh MP, et al. The effectiveness and security of X-PDT for cutaneous squamous cell carcinoma and melanoma. Nanomedicine. 2019;14:2027–43.
Ma L, Chen W, Schatte G, Wang W, Joly AG, Huang Y, et al. A brand new Cu-cysteamine complicated: construction and optical properties. J Mater Chem C Mater. 2014;2:4239–46.
Pandey NK, Chudal L, Phan J, Lin L, Johnson O, Xing M, et al. A facile technique for the synthesis of copper-cysteamine nanoparticles and research of ROS manufacturing for most cancers remedy. J Mater Chem B. 2019;7:6630–42.
Takahashi J, Murakami M, Mori T, Iwahashi H. Verification of radiodynamic remedy by medical linear accelerator utilizing a mouse melanoma tumor mannequin. Sci Rep. 2018;8:1–9.
Hasegawa T, Takahashi J, Nagasawa S, Doi M, Moriyama A, Iwahashi H. Dna strand break properties of protoporphyrin IX by X-ray irradiation towards melanoma. Int J Mol Sci. 2020;21:2302.
Mármol I, Sánchez-de-Diego C, Dieste AP, Cerrada E, Yoldi MJR. Colorectal carcinoma: a basic overview and future views in colorectal most cancers. Int J Mol Sci. 2017;18:197.
Sameer AS. Colorectal most cancers: molecular mutations and polymorphisms. Entrance Oncol. 2013;3:114.
Stintzing S. Administration of colorectal most cancers. Prime Rep. 2014;6:108.
Sang R, Deng F, Engel A, Goldys E, Deng W. Lipid-polymer nanocarrier platform allows X-ray induced photodynamic remedy towards human colorectal most cancers cells. Biomed Pharmacother. 2022;155: 113837.
Lan G, Ni Ok, Xu R, Lu Ok, Lin Z, Chan C, et al. Nanoscale steel–natural layers for deeply penetrating X-ray-induced photodynamic remedy. Angew Chem. 2017;56:12102–6.
Deng W, McKelvey KJ, Guller A, Fayzullin A, Campbell JM, Clement S, et al. Utility of mitochondrially focused nanoconstructs to neoadjuvant X-ray-induced photodynamic remedy for rectal most cancers. ACS Cent Sci. 2020;6:715–26.
